Health equity
Showing 9 of 0 results
- Health disparities in acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2
Blood and Lymphatic Cancer: Targets and Therapy
- Fairness by design: End-to-end bias evaluation for LLM-generated data
AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning